Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-16.73	35.05	42.09
Graham Fair Price	-32.02	1528.69	2248.72
PEG	64.76	-0.97	-2.77
Price/Book	-22.37	1.84	2.37
Price/Cash Flow	-86.13	10.07	-72.58
Prices/Earnings	93.19	55.49	28.72
Price/Sales	-14.74	10.06	11.80
Price/FCF	-86.13	10.07	-72.58
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-5.36	0.27	0.29
Operating Margin	-15.51	0.12	0.14
ROA	-65.43	< 0.005	0.01
ROE	0.02	< 0.005	-59.82
ROIC	0.01	< 0.005	-41.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.27	< 0.005	1050470.07
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.19	-0.18	7.76
EPS QOQ	-0.10	-0.57	-448.29
FCF QOQ	-1.86	7.00	276.91
Revenue QOQ	< 0.005	-0.02	-328.73
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	91.95	89.45	-2.72
Days Sales Outstanding (DSO)	76.99	65.08	-15.47
Inventory Turnover	0.98	1.01	2.79
Debt/Capitalization	0.37	0.41	10.97
Quick Ratio	1.43	1.42	-0.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3303.74	3543.06	7.24
Cash	1985.79	3175.39	59.91
Capex	-129.80	-125.47	3.34
Free Cash Flow	-107.68	646.33	500.25
Revenue	662.35	646.73	-2.36
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.82	1.68	-7.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.28	-4.33	-1444.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating